-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KS2Hjjr4J1GSGPHUVNglRZDqljn2/2R+MOOzMmB1TbGTNFSL1s3bTptqegzNoHDH knq8Kzj0/Ay5rjPoWb0BbQ== 0001181431-03-017364.txt : 20030805 0001181431-03-017364.hdr.sgml : 20030805 20030805175741 ACCESSION NUMBER: 0001181431-03-017364 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030804 FILED AS OF DATE: 20030805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAZAR MELVIN F CENTRAL INDEX KEY: 0001218403 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 03824652 MAIL ADDRESS: STREET 1: 300 EAST 56TH STREET STREET 2: APT. 18A CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 4 1 rrd15156.xml X0201 42003-08-040 0000316253 ENZO BIOCHEM INC ENZ 0001218403 LAZAR MELVIN F 350 FIFTH AVENUE NEW YORK NY 10118 1000Common Stock2003-08-044M0787512.276A7875DCommon Stock2003-08-045G07875D0DCommon Stock2003-08-044P0300019.78D3000DCommon Stock2003-08-045G07875A7875IBy wifeCommon Stock2003-08-044P0300019.6937A10875IOwned directly by a defined benefit plan in which Mr. Lazar is the sole trustee and beneficiaryStock Option (right to buy)12.2762003-08-044M078750D2003-08-012012-07-31Common Stock78757875DGift to wife.Purchased by Valuation Service Group, Inc. Defined Benefit Plan, a defined benefit plan of which Mr. Lazar is the trustee and the sole beneficiary.Option subject to 2 year vesting period; remaining options will vest on August 1, 2004.Option grant./s/ Melvin F. Lazar2003-08-05 -----END PRIVACY-ENHANCED MESSAGE-----